REFRAT CAPSULES 250MG
Product details
Registration number: SIN14674P
Classification: Prescription Only
Active ingredients: Mycophenolate mofetil
Strength: 250mg
Dosage form: CAPSULE
Route: ORAL
Registrant: STRIDES PHARMA GLOBAL PTE. LIMITED
ATC code: L04AA06
HSA approval date: 20 November 2014
Manufacturer(s): Strides Pharma Science Limited
Manufacturing country/countries: INDIA
What are the HSA registration number and classification for REFRAT CAPSULES 250MG?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14674P
Classification: Prescription Only
What active ingredients and strength are recorded for REFRAT CAPSULES 250MG?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Mycophenolate mofetil
Strength: 250mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for REFRAT CAPSULES 250MG?
According to the HSA dataset updated 7 August 2026:
Dosage form: CAPSULE
Route: ORAL
Who is the recorded registrant for REFRAT CAPSULES 250MG?
According to the HSA dataset updated 7 August 2026:
Registrant: STRIDES PHARMA GLOBAL PTE. LIMITED
Which manufacturers and countries are listed for REFRAT CAPSULES 250MG?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Strides Pharma Science Limited
Manufacturing country/countries: INDIA
Where can I look up REFRAT CAPSULES 250MG in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14674P or the exact product name REFRAT CAPSULES 250MG. The general register link does not preselect this product.
What are the source dates for this REFRAT CAPSULES 250MG record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this REFRAT CAPSULES 250MG record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14674P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)